In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes

Abstract EN

Adenosine monophosphate-activated protein kinase (AMPK) acts as a master mediator of metabolic homeostasis.

It is considered as a significant millstone to treat metabolic syndromes including obesity, diabetes, and fatty liver.

It can sense cellular energy or nutrient status by switching on the catabolic pathways.

Investigation of AMPK has new findings recently.

AMPK can inhibit cell growth by the way of autophagy.

Thus AMPK has become a hot target for small molecular drug design of tumor inhibition.

Activation of AMPK must undergo certain extent change of the structure.

Through the methods of structure-based virtual screening and molecular dynamics simulation, we attempted to find out appropriate small compounds from the world’s largest TCM Database@Taiwan that had the ability to activate the function of AMPK.

Finally, we found that two TCM compounds, eugenyl_beta-D-glucopyranoside and 6-O-cinnamoyl-D-glucopyranose, had the qualification to be AMPK agonist.